Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
polyethylene glycol (1 trial)
sodium picosulfate (Preopik) (1 trial)
nrl0706 (1 trial)
poractant alfa (curosurf) (1 trial)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 4)
Trials (3 total)
Trial APIs (4 total)